Biovet JSC (LTS:0III) PB Ratio: 0.00 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biovet JSC PB Ratio?

Biovet JSC LTS:0III PB Ratio is 0.00 as of Jul. 16, 2026. The stock has 1 warning sign investors should review.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-16), Biovet JSC's share price is лв0.00. Biovet JSC's Book Value per Share for the quarter that ended in Dec. 2016 was лв19.43. Hence, Biovet JSC's PB Ratio of today is 0.00.

Good Sign:

Biovet JSC stock PB Ratio (=0.75) is close to 1-year low of 0.69

The historical rank and industry rank for Biovet JSC's PB Ratio or its related term are showing as below:

LTS:0III' s PB Ratio Range Over the Past 10 Years
Min: 0.61   Med: 0.75   Max: 1.15
Current: 0.75

During the past 8 years, Biovet JSC's highest PB Ratio was 1.15. The lowest was 0.61. And the median was 0.75.

LTS:0III's PB Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.955 vs LTS:0III: 0.75

During the past 12 months, Biovet JSC's average Book Value Per Share Growth Rate was 14.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 13.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 13.30% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Biovet JSC was 13.90% per year. The lowest was 7.40% per year. And the median was 13.30% per year.

Back to Basics: PB Ratio


Biovet JSC  (LTS:0III) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biovet JSC PB Ratio Related Terms


Biovet JSC PB Ratio Historical Data

* Premium members only.

The historical data trend for Biovet JSC's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC PB Ratio Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
PB Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LTS:0III vs ADMP, AGRX, BUDZ: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biovet JSC's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovet JSC PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biovet JSC's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biovet JSC's PB Ratio falls into.



Biovet JSC PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biovet JSC's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2016)
=0.00/19.427
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 0.00 mean?
Biovet JSC (LTS:0III) has a PB Ratio of 0.00 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Biovet JSC and its competitors. Over the past decade, Biovet JSC's PB Ratio has ranged from 0.61 to 1.15.
Is Biovet JSC's PB Ratio too high?
Biovet JSC's current PB Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 1.15.
How does Biovet JSC's PB Ratio compare to ADMP and AGRX?
Biovet JSC's PB Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median PB Ratio is 1.96. Historically, Biovet JSC's own PB Ratio has ranged from 0.61 to 1.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.96, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Biovet JSC and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biovet JSC's current PB Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current PB Ratio of 0.00. The current PB Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current PB Ratio is 0.00 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.